非编码RNA在高氧诱导急性肺损伤中作用的研究进展
高氧诱导急性肺损伤(HALI)是临床氧疗的重要并发症,成人主要表现为急性呼吸窘迫综合征(ARDS),婴儿主要表现为支气管肺发育不良(BPD),严重影响患者预后与生活质量。HALI发病机制复杂且不明确,目前尚无明确治疗方法。非编码RNA(ncRNA)缺乏有效开放阅读框、不编码蛋白质,但仍可在多个层面调控基因表达并影响多种疾病的发生发展。近年来大量体外和体内研究显示ncRNA参与HALI的发病机制且意义重大,本文综述ncRNA在HALI中的表达及意义,以期为HALI的防治提供新的诊疗思路。
要点
- HALI是临床氧疗的重要并发症,成人主要表现为ARDS,婴儿主要表现为BPD,严重影响预后与生活质量。
- HALI发病机制复杂且不明确,目前尚无明确治疗方法。
- ncRNA缺乏有效开放阅读框、不编码蛋白质,但仍可在多个层面调控基因表达并影响多种疾病的发生发展。
- 近年大量体外和体内研究显示ncRNA参与HALI的发病机制且意义重大。
- 本文综述ncRNA在HALI中的表达及意义,以期为HALI的防治提供新的诊疗思路。
适用人群与场景
- 接受临床氧疗、发生高氧诱导急性肺损伤(HALI)的成人(主要表现为急性呼吸窘迫综合征,ARDS)与婴儿(主要表现为支气管肺发育不良,BPD)。
研究设计与关键结果
- 本文为综述,汇总近年大量体外和体内研究,显示非编码RNA(ncRNA)参与HALI的发病机制且意义重大,并综述ncRNA在HALI中的表达及意义。
证据类型、等级与局限
- 证据类型:综述;文中汇总的证据来自体外和体内研究。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Hyperoxia-induced acute lung injury (HALI) is an important complication of clinical oxygen therapy, which is mainly characterized by acute respiratory distress syndrome (ARDS) in adults and broncho-pulmonary dysplasia (BPD) in infants. HALI seriously affects the prognosis and quality of life of patients, so it has received more and more attention. However, the pathogenesis of HALI is complex and unclear, and there is no clear treatment method at present. Non-coding RNA (ncRNA) is an important type of functional RNA transcriptome. Due to the lack of effective open reading frame, ncRNA does not have the function of coding proteins. However, ncRNA can still regulate gene expression at multiple levels and affect the occurrence and development of many diseases. In recent years, a large number of in vitro and in vivo studies have shown that ncRNA is involved in the pathogenesis of HALI and is of great significance. This article reviews the expression and significance of ncRNA in HALI, in order to provide new diagnosis and treatment ideas for the prevention and treatment of HALI.
参考来源
- Wang T, Yin G, Liu G, et al. [Research progress of the role of non-coding RNA in hyperoxia-induced acute lung injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38813641. doi:10.3760/cma.j.cn121430-20230809-00597
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。